Trials / Sponsors / Eveliqure Biotechnologies GmbH
Eveliqure Biotechnologies GmbH
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and E Shigella | Phase 2 | 2025-06-30 |
| Completed | ShigETEC Vaccine Study in Bangladesh Healthy Volunteers | Phase 1 | 2023-11-26 |
| Completed | Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combinati Diarrheal Disease, Infectious, Gastrointestinal Disease, Reactive Arthritis | Phase 1 | 2020-09-16 |